Bio-Rad Laboratories EBITDA Margin 2006-2021 | BIO.B

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bio-Rad Laboratories (BIO.B) over the last 10 years. The current EBITDA margin for Bio-Rad Laboratories as of September 30, 2021 is .
Bio-Rad Laboratories EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2021-09-30 $2.98B $0.56B 18.72%
2021-06-30 $2.88B $0.51B 17.74%
2021-03-31 $2.70B $0.44B 16.22%
2020-12-31 $2.55B $0.41B 16.14%
2020-09-30 $2.38B $0.30B 12.39%
2020-06-30 $2.29B $0.24B 10.55%
2020-03-31 $2.33B $0.25B 10.56%
2019-12-31 $2.31B $0.23B 9.90%
2019-09-30 $2.31B $-0.06B -2.47%
2019-06-30 $2.29B $-0.04B -1.88%
2019-03-31 $2.29B $-0.06B -2.40%
2018-12-31 $2.29B $-0.07B -2.97%
2018-09-30 $2.29B $0.22B 9.37%
2018-06-30 $2.28B $0.22B 9.55%
2018-03-31 $2.21B $0.21B 9.45%
2017-12-31 $2.16B $0.23B 10.42%
2017-09-30 $2.11B $0.15B 7.01%
2017-06-30 $2.09B $0.14B 6.76%
2017-03-31 $2.10B $0.17B 7.92%
2016-12-31 $2.07B $0.17B 8.03%
2016-09-30 $2.07B $0.25B 11.90%
2016-06-30 $2.03B $0.21B 10.45%
2016-03-31 $2.02B $0.19B 9.51%
2015-12-31 $2.02B $0.17B 8.22%
2015-09-30 $2.05B $0.16B 7.72%
2015-06-30 $2.11B $0.16B 7.50%
2015-03-31 $2.14B $0.16B 7.67%
2014-12-31 $2.18B $0.15B 6.90%
2014-09-30 $2.18B $0.15B 6.93%
2014-06-30 $2.15B $0.15B 6.82%
2014-03-31 $2.14B $0.15B 7.19%
2013-12-31 $2.13B $0.17B 7.92%
2013-09-30 $2.10B $0.19B 8.94%
2013-06-30 $2.10B $0.23B 10.72%
2013-03-31 $2.08B $0.25B 11.76%
2012-12-31 $2.07B $0.26B 12.76%
2012-09-30 $2.05B $0.29B 14.13%
2012-06-30 $2.06B $0.30B 14.40%
2012-03-31 $2.08B $0.29B 14.07%
2011-12-31 $2.07B $0.31B 14.71%
2011-09-30 $2.06B $0.29B 13.95%
2011-06-30 $2.01B $0.29B 14.31%
2011-03-31 $1.96B $0.29B 14.70%
2010-12-31 $1.93B $0.28B 14.73%
2010-09-30 $1.89B $0.26B 13.87%
2010-06-30 $1.88B $0.25B 13.53%
2010-03-31 $1.84B $0.24B 13.17%
2009-12-31 $1.78B $0.23B 12.89%
2009-09-30 $1.74B $0.20B 11.28%
2009-06-30 $1.72B $0.18B 10.48%
2009-03-31 $1.74B $0.18B 10.56%
2008-12-31 $1.76B $0.18B 10.37%
2008-09-30 $1.78B $0.18B 10.36%
2008-06-30 $1.67B $0.17B 10.22%
2008-03-31 $1.56B $0.15B 9.42%
2007-12-31 $1.46B $0.14B 9.30%
2007-09-30 $1.35B $0.14B 10.33%
2007-06-30 $1.31B $0.13B 10.00%
2007-03-31 $1.29B $0.14B 10.71%
2006-12-31 $1.27B $0.15B 11.46%
2006-09-30 $1.24B $0.14B 11.47%
2006-06-30 $1.22B $0.14B 11.27%
2006-03-31 $1.19B $0.12B 10.26%
2005-12-31 $1.18B $0.12B 9.75%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.038B $2.546B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88